CLINICAL_TRIALS
trial_result
· 2026-02-03
Clinical Trial Update: Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment [Phase 3]
Summary
A Phase 3 clinical trial evaluating buprenorphine to bridge probationers and parolees with opioid use disorder into treatment has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Friends Research Institute, Inc. | Conditions: Opioid Use | Phase 3 | Status: SUSPENDED